CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Open-market sale Director sold 21,267 shares at $3.61 ($76,774)
- 4 Open-market sale Chief R&D Officer sold 73,716 shares at $4.65 ($342,779)
- 4 Open-market sale Chief R&D Officer sold 10,560 shares at $4.76 ($50,266)
- 4 Open-market sale SVP & General Counsel sold 3,189 shares at $4.76 ($15,180)
- 4 Open-market sale SVP & Chief Accounting Officer sold 2,006 shares at $4.76 ($9,549)
- 4 Open-market sale President & CEO sold 13,759 shares at $4.76 ($65,493)
- 4 Open-market sale Chief R&D Officer sold 21,673 shares at $3.95 ($85,608)
- 4 Open-market sale SVP & General Counsel sold 3,136 shares at $3.95 ($12,387)
- 4 Open-market sale SVP & Chief Accounting Officer sold 5,841 shares at $3.95 ($23,072)
- 4 Open-market sale President & CEO sold 36,529 shares at $3.95 ($144,290)
- 4 Open-market sale SVP & Chief Commercial Officer sold 4,592 shares at $3.95 ($18,138)
- 4 Open-market sale SVP, COO & CFO sold 17,448 shares at $3.95 ($68,920)
- 4 Open-market sale Chief R&D Officer sold 10,912 shares at $10.95 ($119,486)
- 4 Open-market sale SVP & General Counsel sold 3,661 shares at $10.95 ($40,088)
Page 6 of 49 · 968 filings